Document Type: Policy Brief
Department of Health Management and Economics, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran
Department of Pharmacoeconomics and Pharmaceutical Administration, Faculty of Pharmacy, and Pharmaceutical Economics and Decision-Making Research Center, Tehran University of Medical Sciences, Tehran, Iran
National Committee on Rational Medicine Use, Food and Drug Administration, Ministry of Health and Medical Education, Tehran, Iran
Department of Global Health and Public Policy, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran
Injection is one of the most common medical procedures in the health sector. Annually up to 16 billion injections are prescribed in low- and middle-income countries (LMICs), many of them are not necessary for the patients, increase the healthcare costs and may result in side effects. Currently over 40% of outpatient prescriptions in Iran contain at least one injectable medicine. To address the issue, a working group was established (August 2014 to April 2015) to provide a comprehensive policy brief to be used by national decision-makers. This report is the extract of methods that were followed and the main policy options for improving injectable medicines prescribing in outpatient services. Thirty-three potential policy options were developed focusing on different stakeholders. The panel reached consensus on seven policy options, noting effectiveness, cost, durability, and feasibility of each policy. The recommended policy options are targeted at patients and public (2 policies), insurers (2), physicians (1), pharmacies (1), and the Ministry of Health and Medical Education (MoHME) (1).